eDreams ODIGEO S.A. (0QS9.L)
EUR 7.76
(0.77%)
EUR 7.76
(0.77%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 118.06 Million | 102.53 Million | 119.14 Million | 428 Thousand | -101.35 Million | 75.46 Million |
| Net Income | 32.35 Million | -43.33 Million | -65.86 Million | -124.22 Million | -40.52 Million | 9.52 Million |
| Depreciation & Amortization | 37.77 Million | 33.83 Million | 33.69 Million | 35.35 Million | 34.52 Million | 26.05 Million |
| Deferred income taxes | -20.49 Million | 4.25 Million | -13.44 Million | -9.35 Million | 82.29 Million | -2.43 Million |
| Stock-based compensation | 16.71 Million | 11.22 Million | 10.52 Million | 6.11 Million | 2.96 Million | 3.37 Million |
| Change in working capital | 49.04 Million | 69.37 Million | 114.96 Million | 65 Million | -207.4 Million | -23.8 Million |
| Other non-cash items | 94.93 Million | 27.18 Million | 39.27 Million | 27.53 Million | 26.79 Million | 62.75 Million |
| Investing Cash Flow | -48.8 Million | -38.14 Million | -26.91 Million | -21.65 Million | -36.2 Million | -28.8 Million |
| Investments in PPE | -49.14 Million | -38.16 Million | -26.92 Million | -21.7 Million | -30 Million | -28.87 Million |
| Acquisitions | 17 Thousand | 38.16 Million | 26.92 Million | 21.7 Million | -6.45 Million | 28.87 Million |
| Investment purchases | -7000.00 | -236 Thousand | -119 Thousand | -20 Thousand | -20 Thousand | -58 Thousand |
| Sales/Maturities of investments | 337 Thousand | 231 Thousand | 116 Thousand | 71 Thousand | 277 Thousand | 119 Thousand |
| Other Investing Activities | -49.13 Million | -38.14 Million | -26.91 Million | -21.7 Million | - | -28.87 Million |
| Financing Cash Flow | -10.23 Million | -67.74 Million | -50.93 Million | -69.45 Million | 74.86 Million | -68.47 Million |
| Debt repayment | -6.25 Million | -121.53 Million | -506.66 Million | -56.98 Million | -3.09 Million | -428.48 Million |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | -1.67 Million | - | - | - | -7.93 Million | -375 Thousand |
| Common Stock Issuance | - | -3.71 Million | 75 Million | - | 1.92 Million | - |
| Other Financing Activities | -2.3 Million | 57.5 Million | 380.73 Million | -12.46 Million | 169.72 Million | 360.37 Million |
| Accounts receivables | - | - | - | - | - | - |
| Accounts payables | - | - | - | - | - | - |
| Inventory | - | - | - | - | - | - |
| Other working capital | 49.04 Million | - | - | - | - | - |
| Cash at beginning of period | 35.93 Million | 45.92 Million | 12.13 Million | 83.33 Million | 148.83 Million | 171.5 Million |
| Cash at end of period | 91.2 Million | 32.05 Million | 36 Million | -4.5 Million | 83.33 Million | 148.83 Million |
| Capital Expenditure | -49.14 Million | -38.16 Million | -26.92 Million | -21.7 Million | -30 Million | -28.87 Million |
| Effect of forex changes on cash | 123 Thousand | -595 Thousand | -789 Thousand | 2.83 Million | -2.79 Million | -846 Thousand |
| Net cash flow / Change in cash | 55.27 Million | -13.87 Million | 23.86 Million | -87.84 Million | -65.49 Million | -22.67 Million |
| Free Cash Flow | 68.92 Million | 64.36 Million | 92.22 Million | -21.27 Million | -131.36 Million | 46.59 Million |
| Breakdown | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -1.18 Million | 32.35 Million | 36.33 Million | -2.36 Million | -5.69 Million | 4.08 Million |
| Depreciation & Amortization | 10.48 Million | 37.77 Million | 9.48 Million | 9.64 Million | 9.38 Million | 9.25 Million |
| Deferred income taxes | - | -20.49 Million | -20.49 Million | -23.46 Million | 126 Thousand | 4.75 Million |
| Stock-based compensation | 3.79 Million | 16.71 Million | 5.45 Million | 4.17 Million | 4.18 Million | 2.91 Million |
| Change in working capital | 6.84 Million | 49.04 Million | 43.43 Million | -26.12 Million | 40.98 Million | -9.25 Million |
| Other non-cash items | 33 Million | 94.93 Million | 18.02 Million | 25.31 Million | 6.39 Million | 6.52 Million |
| Investing Cash Flow | -14.74 Million | -48.8 Million | -12.77 Million | -13.02 Million | -12.23 Million | -10.77 Million |
| Investments in PPE | -14.74 Million | -49.14 Million | -13.09 Million | -13.04 Million | -12.23 Million | -10.77 Million |
| Acquisitions | - | 17 Thousand | -3000.00 | 20 Thousand | - | - |
| Investment purchases | - | -7000.00 | -7000.00 | - | - | - |
| Sales/Maturities of investments | 3000.00 | 337 Thousand | 337 Thousand | - | - | - |
| Other Investing Activities | 3000.00 | - | - | - | - | - |
| Financing Cash Flow | -5.42 Million | -10.23 Million | -4.55 Million | 414 Thousand | -11.46 Million | -5.2 Million |
| Debt repayment | -656 Thousand | -6.25 Million | -573 Thousand | -783 Thousand | -524 Thousand | -4.37 Million |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | -4.76 Million | -1.67 Million | -1.67 Million | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | -709 Thousand | -2.3 Million | -2.3 Million | 1.19 Million | -10.94 Million | -830 Thousand |
| Accounts receivables | - | - | - | - | - | - |
| Accounts payables | - | - | - | - | - | - |
| Inventory | - | - | - | - | - | - |
| Other working capital | 6.84 Million | - | - | - | - | - |
| Cash at beginning of period | 91.2 Million | 35.93 Million | 46.93 Million | 66.47 Million | 34.59 Million | 32.05 Million |
| Cash at end of period | 99.49 Million | 91.2 Million | 91.2 Million | 46.93 Million | 66.47 Million | 34.59 Million |
| Capital Expenditure | -14.74 Million | -49.14 Million | -13.09 Million | -13.04 Million | -12.23 Million | -10.77 Million |
| Effect of forex changes on cash | 258 Thousand | 123 Thousand | -9000.00 | -314 Thousand | 210 Thousand | 236 Thousand |
| Net cash flow / Change in cash | 8.28 Million | 55.27 Million | 44.26 Million | -19.53 Million | 31.88 Million | 2.54 Million |
| Free Cash Flow | 13.44 Million | 68.92 Million | 54.71 Million | -25.86 Million | 43.14 Million | 7.51 Million |
ARE&M
SYMPHONY
8115
NNLRF
6590
8631